CYP46A1 activation by low-dose efavirenz enhances brain cholesterol metabolism in subjects with early Alzheimer’s disease

被引：0
|
作者：
Alan J. Lerner
Steven E. Arnold
Erin Maxfield
Aaron Koenig
Maria E. Toth
Brooke Fortin
Natalia Mast
Bianca A. Trombetta
John Denker
Andrew A. Pieper
Curtis Tatsuoka
Sangeetha Raghupathy
Irina A. Pikuleva
机构：
[1] Brain Health and Memory Center,Department of Neurology
[2] Neurological Institute,Alzheimer’s Clinical and Translational Research Unit
[3] University Hospitals Cleveland Medical Center,Department of Ophthalmology and Visual Sciences
[4] Case Western Reserve University,Harrington Discovery Institute
[5] Massachusetts General Hospital,Department of Psychiatry
[6] Case Western Reserve University,Institute for Transformative Molecular Medicine, School of Medicine
[7] University Hospitals Cleveland Medical Center,Department of Population and Quantitative Health Sciences
[8] Case Western Reserve University,undefined
[9] Geriatric Psychiatry,undefined
[10] GRECC,undefined
[11] Louis Stokes Cleveland VA Medical Center,undefined
[12] Case Western Reserve University,undefined
[13] Case Western Reserve University,undefined
来源：
Alzheimer's Research & Therapy | / 14卷
关键词：
CYP46A1; Efavirenz; Alzheimer’s disease; 24-Hydroxycholesterol; Stable isotope labeling kinetics;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Proteomic alterations of brain subcellular organelles caused by low-dose copper exposure: implication for Alzheimer's disease
    Yu, Haitao
    Wang, Dian
    Zou, Liangyu
    Zhang, Zaijun
    Xu, Hua
    Zhu, Feiqi
    Ren, Xiaohu
    Xu, Benhong
    Yuan, Jianhui
    Liu, Jianjun
    Spencer, Peter S.
    Yang, Xifei
    ARCHIVES OF TOXICOLOGY, 2018, 92 (04) : 1363 - 1382
  • [42] Proteomic alterations of brain subcellular organelles caused by low-dose copper exposure: implication for Alzheimer’s disease
    Haitao Yu
    Dian Wang
    Liangyu Zou
    Zaijun Zhang
    Hua Xu
    Feiqi Zhu
    Xiaohu Ren
    Benhong Xu
    Jianhui Yuan
    Jianjun Liu
    Peter S. Spencer
    Xifei Yang
    Archives of Toxicology, 2018, 92 : 1363 - 1382
  • [43] Quantification of Cholesterol-Metabolizing P450s CYP27A1 and CYP46A1 in Neural Tissues Reveals a Lack of Enzyme-Product Correlations in Human Retina but Not Human Brain
    Liao, Wei-Li
    Heo, Gun-Young
    Dodder, Nathan G.
    Reem, Rachel E.
    Mast, Natalia
    Huang, Suber
    DiPatre, Pier Luigi
    Turko, Illarion V.
    Pikuleva, Irina A.
    JOURNAL OF PROTEOME RESEARCH, 2011, 10 (01) : 241 - 248
  • [44] Systemic delivery of the brain-targeting AAV-PHPeB encoding the cholesterol hydroxylase CYP46A1 into a mouse model of Machado-Joseph disease: a promising therapeutic strategy
    Serra, B.
    Duarte, S. P.
    Cartier, N.
    Alves, S.
    de Almeida, L. P.
    Perfeito, R.
    HUMAN GENE THERAPY, 2022, 33 (23-24) : A85 - A85
  • [45] Early Brain Response to Low-Dose Radiation Exposure Involves Molecular Networks and Pathways Associated with Cognitive Functions, Advanced Aging and Alzheimer's Disease
    Lowe, Xiu R.
    Bhattacharya, Sanchita
    Marchetti, Francesco
    Wyrobek, Andrew J.
    RADIATION RESEARCH, 2009, 171 (01) : 53 - 65
  • [46] Clinical Approach of Low-Dose Whole-Brain Ionizing Radiation Treatment in Alzheimer's Disease Dementia Patients
    Chung, Mijoo
    Chung, Weon Kuu
    JOURNAL OF ALZHEIMERS DISEASE, 2021, 80 (03) : 941 - 947
  • [47] Low glucose metabolism during brain stimulation in older Down's syndrome subjects at risk for Alzheimer's disease prior to dementia
    Pietrini, P
    Dani, A
    Furey, ML
    Alexander, GE
    Freo, U
    Grady, CL
    Mentis, MJ
    Mangot, D
    Simon, EW
    Horwitz, B
    Haxby, JV
    Schapiro, MB
    AMERICAN JOURNAL OF PSYCHIATRY, 1997, 154 (08): : 1063 - 1069
  • [48] CYP46A1 intron-2T/C polymorphism and Alzheimer's disease: An updated meta-analysis of 16 studies including 3960 cases and 3828 controls
    Li, Min
    Wang, Wei
    Li, Yanping
    Wang, Lei
    Shen, Xiaoping
    Tang, Zhenyu
    NEUROSCIENCE LETTERS, 2013, 549 : 18 - 23
  • [49] A phase 1 open-label pilot study of low-dose interleukine-2 immunotherapy in patients with Alzheimer's disease
    Faridar, Alireza
    Eid, Abdulmunaim M.
    Thome, Aaron D.
    Zhao, Weihua
    Beers, David R.
    Pascual, Maria B.
    Nakawah, Mohammad O.
    Roman, Gustavo C.
    Davis, Charles S.
    Grundman, Michael
    Masdeu, Joseph C.
    Appel, Stanley H.
    TRANSLATIONAL NEURODEGENERATION, 2023, 12 (01)
  • [50] A phase 1 open-label pilot study of low-dose interleukine-2 immunotherapy in patients with Alzheimer’s disease
    Alireza Faridar
    Abdulmunaim M. Eid
    Aaron D. Thome
    Weihua Zhao
    David R. Beers
    Maria B. Pascual
    Mohammad O. Nakawah
    Gustavo C. Roman
    Charles S. Davis
    Michael Grundman
    Joseph C. Masdeu
    Stanley H. Appel
    Translational Neurodegeneration, 12
12345